oncology companies

Companies whose enriched business profile is tagged “oncology”, drawn from their SEC filings + website text. Sorted by market capitalization; every figure is delayed data from SEC EDGAR + market data, shown with its as-of date.

• Lilly (Eli) (LLY) Health Care — Eli Lilly is a global pharmaceutical innovator leading the market in metabolic health, including diabetes and obesity treatments, alongside a diverse portfolio of oncology and immunology therapies. ask →
• AbbVie (ABBV) Health Care — A global biopharmaceutical leader focused on developing innovative, specialized therapies for immunology, oncology, neuroscience, and aesthetic medicine. ask →
• Amgen (AMGN) Health Care — Amgen is a leading biotechnology firm dedicated to developing innovative human therapeutics to address critical unmet needs in areas like oncology, inflammation, and cardiovascular disease. ask →
• NOVARTIS AG (NVS) Health Care — Global pharmaceutical and biotechnology company pioneering disease-modifying treatments across oncology, immunology, neuroscience, and rare genetic diseases. ask →
• ASTRAZENECA PLC (AZN) Health Care — AstraZeneca is a major global biopharmaceutical company dedicated to delivering life-changing medicines across oncology, rare diseases, and diverse chronic conditions. ask →
• Pfizer (PFE) Health Care — A diversified, global biopharmaceutical giant focused on discovering and commercializing life-changing medicines, vaccines, and advanced therapies across key therapeutic areas. ask →
• Moderna (MRNA) Health Care — Moderna is a pioneer in mRNA technology, working to transform medicine by developing a broad pipeline of prophylactic vaccines and therapeutic medicines. ask →
• Incyte (INCY) Health Care — Incyte is a biopharmaceutical company focused on discovering and developing innovative medicines for oncology and inflammatory conditions. ask →
• Exelixis (EXEL) Health Care — Exelixis is a commercial-stage oncology biotechnology company with a strong focus on developing small-molecule treatments for various types of cancer. ask →
• Corcept Therapeutics (CORT) Health Care — Corcept Therapeutics is a commercial-stage biotechnology company pioneering cortisol modulation therapies to treat severe endocrine, oncologic, and metabolic conditions. ask →
• Summit Therapeutics (SMMT) Health Care — A biopharmaceutical company dedicated to the clinical advancement of its lead bispecific antibody, ivonescimab, for oncology applications. ask →
• IMMUNITYBIO INC (IBRX) Health Care — ImmunityBio develops innovative immunotherapies and cell-based cancer vaccines that leverage its Cancer BioShield platform to treat oncology and infectious disease patients. ask →
• CG ONCOLOGY INC (CGON) Health Care — CG Oncology is an immuno-oncology company developing bladder-sparing therapeutics for patients with non-muscle invasive bladder cancer. ask →
• ERASCA INC (ERAS) Health Care — Erasca is a precision oncology company dedicated to shutting down the RAS/MAPK pathway to effectively treat patients with cancer. ask →
• CELCUITY INC (CELC) Health Care — Celcuity is a biotechnology company developing gedatolisib, a targeted PI3K/mTOR inhibitor, to treat various cancer indications. ask →
• ENLIVEN THERAPEUTICS INC (ELVN) Health Care — Enliven Therapeutics is a precision oncology company developing next-generation small molecule inhibitors, led by its clinical-stage BCR-ABL program for chronic myeloid leukemia. ask →
• RELAY THERAPEUTICS INC (RLAY) Health Care — Relay Therapeutics is a precision medicine company leveraging a protein-motion discovery platform to develop targeted therapies for oncology and genetic diseases. ask →
• ARCUS BIOSCIENCES INC (RCUS) Health Care — A clinical-stage biopharmaceutical company focused on discovering and developing innovative, small-molecule and antibody-based oncology therapies through a robust pipeline and strategic collaborations. ask →
• IOVANCE BIOTHERAPEUTICS INC (IOVA) Health Care — Iovance is a pioneer in tumor infiltrating lymphocyte (TIL) cell therapy, offering the first one-time, individualized T cell treatment for advanced solid tumor cancers. ask →
• IMMUNOME INC (IMNM) Health Care — Immunome is a clinical-stage biotechnology company leveraging a proprietary platform to discover and develop novel, targeted oncology therapeutics. ask →
• CELLDEX THERAPEUTICS INC (CLDX) Health Care — Celldex Therapeutics is a clinical-stage biotechnology firm developing novel monoclonal antibodies and antibody-drug conjugates to treat complex inflammatory and oncology diseases. ask →
• SELLAS LIFE SCIENCES GROUP INC (SLS) Health Care — SELLAS Life Sciences is a clinical-stage biotech developing novel immunotherapies to address hematologic and solid tumor cancers. ask →
• NURIX THERAPEUTICS INC (NRIX) Health Care — Clinical-stage biotech pioneering AI-powered targeted protein degradation medicines for cancer and autoimmune diseases, with Phase 2 lead candidate bexobrutideg in CLL and partnerships spanning Roche, Gilead, and Sanofi. ask →
• BIOHAVEN LTD (BHVN) Health Care — Biohaven is a biopharmaceutical firm developing a diverse pipeline of innovative therapies for complex diseases in neuroscience, immunology, obesity, and oncology. ask →
• XENCOR INC (XNCR) Health Care — A clinical-stage biopharmaceutical company developing engineered monoclonal antibodies and cytokines using its proprietary protein engineering platforms to treat cancer and autoimmune diseases. ask →
• ZYMEWORKS INC (ZYME) Health Care — A clinical-stage biotechnology firm building value through a portfolio of novel multifunctional biotherapeutics and strategic royalty assets. ask →
• NOVOCURE LTD (NVCR) Health Care — Novocure is an oncology company utilizing proprietary Tumor Treating Fields (TTFields) to disrupt cancer cell division through wearable, non-invasive electric field therapy. ask →
• BICARA THERAPEUTICS INC (BCAX) Health Care — Bicara Therapeutics is developing a pipeline of bifunctional antibodies that precisely target and neutralize both EGFR and TGF-β pathways to improve treatment outcomes in solid tumors. ask →
• VOR BIOPHARMA INC (VOR) Health Care — Vor Biopharma is a clinical-stage biopharmaceutical company developing advanced cell therapy and gene therapy solutions for blood disorders and cancers. ask →
• MONTE ROSA THERAPEUTICS INC (GLUE) Health Care — Monte Rosa Therapeutics develops molecular glue degraders—a novel class of protein degradation drugs targeting historically undruggable proteins through its proprietary QuEEN discovery platform. ask →
• KURA ONCOLOGY INC (KURA) Health Care — Clinical-stage oncology company commercializing KOMZIFTI for cancer and advancing a pipeline of targeted therapeutics through strategic partnerships. ask →
• AURA BIOSCIENCES INC (AURA) Health Care — Aura Biosciences is a clinical-stage biotech developing precision Viral-like Drug Conjugate (VDC) therapies designed to treat solid tumors while preserving organ function. ask →
• CYTOMX THERAPEUTICS INC (CTMX) Health Care — CytomX is developing conditionally activated cancer therapies using its PROBODY platform to enable selective tumor targeting with reduced systemic toxicity, starting with varsetatug masetecan for colorectal cancer. ask →
• VERASTEM INC (VSTM) Health Care — A biopharmaceutical company developing targeted therapies for RAS/MAPK pathway-driven cancers, with a newly FDA-approved combination treatment for KRAS-mutated ovarian cancer and a pipeline focused on direct KRAS G12D inhibition. ask →
• ARTIVA BIOTHERAPEUTICS INC (ARTV) Health Care — Artiva Biotherapeutics develops allogeneic natural killer cell immunotherapies for cancer, with its lead candidate AlloNK advancing through clinical trials. ask →
• COMPASS THERAPEUTICS (CMPX) Health Care — Compass Therapeutics is a clinical-stage oncology company developing a pipeline of bispecific and agonistic antibodies designed to treat solid tumors by targeting angiogenesis and immune system pathways. ask →
• FOGHORN THERAPEUTICS INC (FHTX) Health Care — Precision biotechnology company developing chromatin-targeting small molecule therapeutics to treat cancer and other serious diseases by correcting abnormal gene expression. ask →
• PERSPECTIVE THERAPEUTICS INC (CATX) Health Care — Perspective Therapeutics is a clinical-stage oncology company pioneering targeted alpha therapy (TAT) to treat cancer through a proprietary radiopharmaceutical platform. ask →
• ADC THERAPEUTICS SA (ADCT) Health Care — ADC Therapeutics develops antibody-drug conjugates (ADCs) targeting hematologic and solid tumors, with its lead product ZYNLONTA commercialized for lymphoma. ask →

Not quite it? Describe exactly what you want →

Data: SEC EDGAR (filings) + market data (fundamentals, delayed daily-close). Figures shown with their as-of date.

Last updated 2026-08-24.

Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date.